Find 2-Methoxyestradiol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 362-07-2, Panzem, 2-methoxyestradiol-17beta, 2-hydroxyestradol 2-methyl ether, 2-me2, 2me2
Molecular Formula
C19H26O3
Molecular Weight
302.4  g/mol
InChI Key
CQOQDQWUFQDJMK-SSTWWWIQSA-N
FDA UNII
6I2QW73SR5

2-Methoxyestradiol
A metabolite of estradiol that lacks estrogenic activity and inhibits TUBULIN polymerization. It has antineoplastic properties, including inhibition of angiogenesis and induction of APOPTOSIS.
1 2D Structure

2-Methoxyestradiol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
2.1.2 InChI
InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1
2.1.3 InChI Key
CQOQDQWUFQDJMK-SSTWWWIQSA-N
2.1.4 Canonical SMILES
CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O
2.1.5 Isomeric SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)OC)O
2.2 Other Identifiers
2.2.1 UNII
6I2QW73SR5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (17 Beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol

2. 2 Methoxyestradiol

3. 2 Methoxyestradiol 17 Beta

4. 2 Methoxyoestradiol

5. 2-(methyl-11c)methoxyestradiol

6. 2-methoxyestradiol, (17alpha)-isomer

7. 2-methoxyestradiol-17 Beta

8. 2-methoxyoestradiol

9. Panzem

2.3.2 Depositor-Supplied Synonyms

1. 362-07-2

2. Panzem

3. 2-methoxyestradiol-17beta

4. 2-hydroxyestradol 2-methyl Ether

5. 2-me2

6. 2me2

7. 2-meoe2

8. Estradiol, 2-methoxy-

9. 2-methoxyestradiol (2-meoe2)

10. 2-methoxyoestradiol

11. 2-hydroxyestradiol 2-methyl Ether

12. 2-methoxy-17beta-estradiol

13. Nsc-659853

14. (17beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol

15. 2-methoxyestra-1,3,5(10)-triene-3,17beta-diol

16. 2-methoxy-estradiol

17. 2-methoxy-beta-estradiol

18. Mls000028819

19. 6i2qw73sr5

20. Chembl299613

21. Chebi:28955

22. Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17beta)-

23. Panzem Ncd

24. 1,3,5(10)-estratrien-2,3,17-beta-triol 2-methyl Ether

25. 2-methoxy-estra-1,3,5(10)-triene-3,17beta-diol

26. Estra-1,3,5(10)-triene-3,17beta-diol, 2-methoxy-

27. (8r,9s,13s,14s,17s)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

28. (8r,9s,13s,14s,17s)-2-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthrene-3,17-diol

29. Smr000058478

30. Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17b)-

31. (17beta)-2-methoxyestra-1(10),2,4-triene-3,17-diol

32. Pulmolar

33. 2-methoxy-.beta.-estradiol

34. Nsc 659853

35. Unii-6i2qw73sr5

36. Ccris 9405

37. 1lhw

38. Mfcd00010489

39. Opera_id_634

40. 2-methoxyestradiol Powder

41. 2-methoxyestradiol, Powder

42. 2-methoxy 17?-estradiol

43. M 6383

44. Schembl8796

45. 2-meo-e2

46. Lopac0_000739

47. Mls001076279

48. Mls006010142

49. Dtxsid3040938

50. Gtpl12058

51. Hms2230l22

52. Hms3262c20

53. Hms3412h22

54. Hms3676h22

55. Bcp02076

56. Zinc3818826

57. 2-methoxyestradiol [who-dd]

58. 2-methoxyoestradiol [mart.]

59. Tox21_500739

60. Bdbm50060957

61. Lmst02010035

62. S1233

63. Akos015901723

64. 2-methoxyestradiol, Analytical Standard

65. Bcp9000109

66. Ccg-204824

67. Cs-0176

68. Db02342

69. Lp00739

70. Sdccgsbi-0050717.p002

71. Smp2_000045

72. Ncgc00094082-03

73. Ncgc00094082-04

74. Ncgc00094082-13

75. Ncgc00261424-01

76. Ac-32086

77. As-19175

78. Bp-25393

79. Hy-12033

80. Eu-0100739

81. M2530

82. C05302

83. C74863

84. Ab00639611-09

85. Ab00639611_10

86. Sr-01000076000

87. 2-methoxy-1,3,5 (10)-estratriene-3,17beta-diol

88. 2-methoxyestra-1,3,5(10)-triene-3,17-diol #

89. Q4596897

90. Sr-01000076000-1

91. Brd-k44408410-001-20-0

92. (17?)-2-methoxyestra-1(10),2,4-triene-3,17-diol

93. (17?)-2-methoxyestra-1,3,5(10)-triene-3,17-diol

94. 17beta-2-methoxyestra-1,3,5(10)-triene-3,17-diol

95. Estra-1,3,5(10)-triene-3,17.beta.-diol, 2-methoxy-

96. Estra-1(10),2,4-triene-3,17-diol, 2-methoxy-, (17beta)-

97. (14beta,17beta)-2-methoxyestra-1(10),2,4-triene-3,17-diol

98. (17.beta.)-2-methoxyestra-1,3,5(10)-triene-3,17-diol

99. B3c40b85-1733-48fe-8418-a39011910d19

100. Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17.beta.)-

2.4 Create Date
2005-06-08
3 Chemical and Physical Properties
Molecular Weight 302.4 g/mol
Molecular Formula C19H26O3
XLogP34
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass302.18819469 g/mol
Monoisotopic Mass302.18819469 g/mol
Topological Polar Surface Area49.7 Ų
Heavy Atom Count22
Formal Charge0
Complexity425
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the treatment of breast cancer and inflammatory diseases such as rheumatoid arthritis.


5 Pharmacology and Biochemistry
5.1 Pharmacology

2-Methoxyestradiol belongs to the family of drugs called angiogenesis inhibitors. It also acts as a vasodilator.


5.2 MeSH Pharmacological Classification

Tubulin Modulators

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


5.3 Metabolism/Metabolites

In vivo metabolism, assessed using 24-h collections of urine from cancer patients treated with 2ME2 revealed that <0.01% of the total administered dose of 2ME2 is excreted unchanged in urine and about 1% excreted as glucuronides. Collectively, this suggests that glucuronidation and subsequent urinary excretion are elimination pathways for 2ME2.


2-O-methoxyestradiol has known human metabolites that include 2-Methoxy-estradiol-17beta 3-glucuronide.

2-O-methoxyestradiol is a known human metabolite of 2-hydroxyestradiol.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.4 Mechanism of Action

2-Methoxyestradiol is an angiogenesis inhibitor, and has been shown to attack both tumor cells and their blood supply in preclinical testing. 2-methoxyestradiol is a naturally occurring estrogen metabolite but has no undesired estrogenic activity.


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty